Age and outcome with contemporary thrombolytic therapy: Results from the GUSTO-I trial Academic Article uri icon

Overview

MeSH Major

  • Aging
  • Myocardial Infarction
  • Thrombolytic Therapy

abstract

  • Lower mortality and greater net clinical benefit were seen with accelerated TPA in patients aged < or = 85 years. Because data are limited for patients aged > 85 years, the relative superiority of a given thrombolytic regimen cannot be determined. The interactions of stroke and mortality with newer thrombolytic strategies must be examined explicitly in older patients.

publication date

  • October 30, 1996

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 8873656

Additional Document Info

start page

  • 1826

end page

  • 33

volume

  • 94

number

  • 8